Recommendations for the evaluation of animal cell cultures ...
Historically, the major concerns regarding the safety of biological medicinal products manufactured in animal cells have been related to the possible presence of microbial contaminants and, in some cases, to the properties and components of the cells themselves such as DNA and proteins.
Tags:
Biological, Medicinal, Biological medicinal
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Good, Practices, Pharmaceutical, Good distribution practices for, Distribution
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating
Related documents
Guideline on similar biological medicinal products ...
www.ema.europa.euThe Guideline on similar biological medicinal products containing biotechnology -derived proteins as active substance: quality issues lays down the quality requirements for a biological medicinal product claiming to be similar to another one already marketed.
Product, Biological, Medicinal, Biotechnology, Containing, Derived, Similar, Similar biological medicinal, Biological medicinal, Similar biological medicinal products containing biotechnology derived
Guideline on similar biological medicinal products ...
www.ema.europa.euGuideline on similar biological medicinal products containing biotechnology -derived proteins as active substance: non-clinical and clinical issues (EMEA/CHMP/BMWP/42832/05 Rev.1) lays down the non-clinical and clinical requirements for a …
Biological, Medicinal, Similar, Similar biological medicinal
Isosteresin Medicinal Chemistry Group Meeting Christos ...
www.scripps.edubiological activity. Thornber(1979): Groups or molecules which have chemical and physical similarities producing broadly similar biological effects. Parameters affected with bioisostericreplacements Size, conformation, inductive and mesomericeffects, polarizability, H-bond formation capacity, pK a, solubility, hydrophobicity, reactivity, stability.
Biological, Chemistry, Group, Meeting, Medicinal, Similar, Isosteresin medicinal chemistry group meeting, Isosteresin, Similar biological
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ec.europa.euThis medicinal product is subject to additional monitoring. This will allow quick identification of ... In order to improve the traceability of biological medicinal products, the name and the batch number . ... baseline, was similar to that seen in the general population. Reporting of suspected adverse reactions .
PRINCIPLES OF MEDICINAL CHEMISTRY
www.ysmubooks.ambetween chemical structure and biological activity, theories of drug action, and mechanism of ... Definition Medicinal chemistry, also called therapeutic chemistry, pharmaceutical chemistry, pharmacochemistry, and chemical pharmacy is that field of pharmaceutical sciences which applies the ... more active, and c) with similar or different ...
Principles, Biological, Chemistry, Medicinal, Similar, Principles of medicinal chemistry
Transport route profiling qualification
www.who.intoverall size and weight should be similar to the container(s) used for the product(s) which are being monitored – this will ensure that the same handling practices are used. Warm life (test): The empty passive container is stabilized at +18.0°C and loaded with warm water-packs, which have been stabilized at the same temperature for a minimum of
Route, Transport, Qualification, Profiling, Transport route profiling qualification, Similar
Implementation Working Group ICH Q11 Guideline ...
database.ich.orgmeaning that the proposed starting material should be structurally similar to the drug substance. However, as stated in ICH Q11, this general principle is intended to help distinguish starting materials from reagents, catalysts, solvents, or other raw materials.